News
-
Oyster Point Pharma has announced top-line results from the Phase 1 ZEN study of its OC-01 varenicline nasal spray, which the company is developing for the treatment of dry eye disease. The PK study, which… Read more . . .
-
According to UCB, Nayzilam midazolam nasal spray will be available in the US as of December 2, 2019. UCB acquired the nasal spray from Proximagen in April 2018, and the FDA approved Nayzilam for the… Read more . . .
-
TFF Pharmaceuticals has announced the initiation of Phase 1 trial of its dry powder voriconazole, which the company is developing for the treatment of invasive pulmonary aspergillosis (IPA). The Phase I SAD/MAD study will be… Read more . . .
-
Inhaler monitoring company Adherium has named Peter Stratford as CEO and Mike Motion as Chief Commercial Officer, replacing interim CEO Jeremy Curnock Cook and interim CCO Bill Hunter. Stratford was most recently Head of Innovation… Read more . . .
-
Lupin has launched its new Adhero connected inhaler monitoring device in India, the company said. According to Lupin, the company collaborated with Aptar Pharma on the device, which attaches to the tops of MDIs. The… Read more . . .
-
The Chinese National Medical Product Administration (NMPA) has approved an investigative new drug (IND) application for Penthrox methoxyflurane inhaler for two different indications, Medical Developments International (MVP or MDI) has announced. MVP is developing Penthrox… Read more . . .
-
By Jason A Suggett, Mark W Nagel, Dominic P Coppolo, and Jolyon P Mitchell A wide spectrum of options is available for delivering inhaled medications by nebulization. The challenge, either for a developer considering which… Read more . . .
-
DPI developer Iconovo has announced that the Japanese Patent Office has granted the company a patent covering its ICOres dry powder inhaler. According to Iconovo, Sweden and European patents related to ICOres have already been… Read more . . .
-
Iliad Biotechnology has announced the appointment of Cheryl Keech as Chief Medical Officer and Executive VP of Clinical Research; she will be responsible for clinical studies of the company’s pipeline products, including the BPZE1 live… Read more . . .
-
Hovione Technology said that the company has completed pilot-scale blister manufacturing and filling for its Papillon dry powder inhaler. The company announced in April 2019 that it had acquired the rights to the DPI from… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.